Articles On Holista CollTech (ASX:HCT)

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

Holista Colltech’s (HCT) subsidiary, Holista Biotech, receives its first commercial order from Country Farms for its food ingredients Country Farms has placed a $43,000 order for Holista’s low glycaemic index (GI) food ingredient, GI Lite...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

The ASX Emerging Companies (XEC) index is busting out after a three-session losing streak that felt like ten days. I should know, I spent a week in Canberra one afternoon when I was about 15. Anyway, the index for sensational small caps is...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Minerals260 (ASX:MI6), a spinoff from Liontown Resources (ASX:LTR), enjoyed a positive debut despite the ASX finishing down again. The ASX 200 retreated 0.26% to close at 7,821 points with all sectors in the red except consumer staples and...

Holista Colltech’s (HCT) subsidiary signs a non-binding collaboration term sheet with Country Farms Owned by Malaysian conglomerate Berjaya Corporation Berhad, Country Farms operates several franchises of international brands in Malaysia...

The ASX retreated again as angst over inflation and the withdrawal of stimulus continued to weigh on global markets. The ASX 200 closed at 7,300 – 0.28% lower than Friday’s close. Tech was the biggest laggard, losing nearly 3% but energy an...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

The ASX 200 closed at 7,488 points which was 0.04% down from yesterday but up 0.37% from last Friday. The ASX Emerging Companies Index lost 0.57% to close at 2,285 points. The best sector was industrials which gained 1.07%. Tech and consume...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The ASX had another positive day but, unlike yesterday, held momentum to close at an all time high. The ASX 200 closed at 7,511 points which was an 0.11% gain although the ASX Emerging Companies Index fell 0.63% to 2,226 points. The top sec...

An ASX-listed company, together with its chief executive, has been accused of spruiking false COVID-killing claims about its products. The Australian Securities and Investments Commission (ASIC) is suing Holista Colltech Limited (ASX: HCT)...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

The ASX rebounded from yesterday’s losses but short of an all time high. The ASX 200 closed at 7,503 points, 0.38% up from yesterday but 6 points behind its intraday high. Meanwhile the ASX Emerging Companies Index gained 0.63% at 2,240 poi...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

The ASX begun the week in positive territory with tech, and energy stocks both gaining over 1 per cent. The ASX 200 closed at 7,024 points, 0.13 per cent higher than Friday’s close. Meanwhile, the ASX Emerging Companies Index surged 1.46 pe...

Friday, and the week ended pretty much the way it began, with loopy comments from Elon Musk diverting everyone’s attention away from real life. BNPLs failed to recover from yesterday’s robust inflation expectations out of the US, and the ma...

The S&P/ASX200 closed lower on Thursday, dropping -62.20 points or -0.88% to 6982.70. However, some stocks gained substantially. Among top gainers were Whitehaven Coal Limited (ASX:WHC) that clocked 5.72% gains, GrainCorp Limited (ASX:...

Perth-based natural wellness company, Holista CollTech (ASX:HTC) is about to market its ovine (sheep) collagen into China. The company’s subsidiary, Holista Biotech, has just announced an exclusive distribution partnership with Malaysia-bas...

Summary Today, Lefroy Exploration announced that it has wrapped up two diamond drill holes in the DD program at Burns. The AGE share price has already delivered 87.5% return in May, including today’s 15.3% rally to AU$0.03. The PEK sh...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Sell-off on Wall Street after inflation rose to highest since 2009 All major indices in US tumbled after US consumer price increased by 0.8% in April, climbing by the most since 2009 and topping estimates. The steeper than expected inflatio...

Small caps have bounced back from a slow start to finish in the green – barely. The Small Ordinaries index finished Friday up 2.6 points, or 0.08 per cent, to 3,318.8, slightly underperforming the All Ordinaries which rose 0.12 per cent. Th...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

27 Nov 2020 - Natural wellness company, Holista Colltech (ASX:HCT) has commissioned an application to allow its NatShieldTM and ProtecteneTM range of products to be labelled as eff…

Summary Holista’s Path-Away® can kill 99.9% of the coronavirus in two minutes on hard surfaces. This test finding on Path-Away® is anticipated to facilitate the listing requirements in “List N” of the USA’s EPA. ...

Natural wellness company Holista CollTech (ASX: HCT) has announced independent tests of Path-Away anti-pathogenic aerosol solution have shown the ingredient can kill 99.9% of the virus that causes COVID-19 within two minutes on a hard surfa...

Holista Colltech (ASX:HCT) shares are up more than 30 per cent after the Perth-based natural wellness company announced tests have ... Read More The post Holista Colltech shares soar after tests show its organic aerosol kills Covid virus ap...

A quick wrap of the ASX’s key winners and losers on Thursday, July 9. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 832 stocks rose, 502 declined and 77...

The ASX small caps focused on the COVID-hammered US are feeling the pinch but are still optimistic about their endeavours. The US has the world’s most COVID-19 cases, surpassing 3 million cases earlier this week and 130,000 deaths. One stoc...

The Holista CollTech Limited (ASX: HCT) share price is bucking the wider market sell-off today after the company announced the acquisition of an advanced skin ingredient. Holista CollTech is a natural wellness company that operates across...

From the company that brought you halal-certified sheep collagen, bald eagle algae, diet noodles and low-sugar sugar, comes certified low-GI tortillas. Holista CollTech (ASX:HCT), which will be more familiar to recent investors as a COVID-1...

Shares in Holista Colltech Limited (ASX:HCT) hit a high of 18 cents on Tuesday after the company announced that it had appointed OOH Medical Ltd as exclusive distributor for the NatshieldTM sanitiser products for the United Kingdom for an i...

The share price of Holista CollTech Limited (ASX: HCT) has leapt 6% today after the company announced it had filed a global patent for its nasal balm. The NatShield nasal balm will contain an anti-pathogenic solution as its active ingredie...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Testing of the plant-based component in Natshield hand sanitisers developed by natural wellness company Holista CollTech (ASX: HCT) has confirmed it to be more than 99.99% effective against feline coronavirus, a surrogate the COVID-19 novel...

Not all change associated with a pandemic is bad. One thing that could potentially change for the better as a result of COVID-19 is people taking a more proactive approach to their healthcare. The latest pandemic is already prompting people...

Natural wellness company Holista CollTech (ASX: HCT) and skincare specialist Skin Elements (ASX: SKN) released a joint statement this morning, announcing a binding deal to launch an alcohol-free hand sanitiser combining Skin Elements’ skin-...

Before 1942, Australia hadn’t fully come to terms with what a world war would require it to do. By the end of 1942, after the Japanese Imperial airforce bombed Darwin, the country was a very different place. It had gone from a tiny populati...

As the global COVID-19 pandemic worsens, Holista CollTech (ASX: HCT) is about to launch its NatShield sanitiser in the United States after appointing Health Therapies as the exclusive distributor for the country. The deal gives Health Thera...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...